ArticleDiscover oncology2026

Risk of metastasis and survival in patients with T1-2 non-ampullary duodenal neuroendocrine tumors undergoing different treatment strategies.

Cheng Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.